I found some more info about GSK increasing Relenza production even beyond the 60 million pack we where made to believe.
They must be expecting some real healthy sales of Relenza in the near future.....
The writing is on the wall
jojo
GSK is also increasing production of Relenza, a drug used to treat the H1N1 flu. It is expected to be able to deliver about 60 million packs a year in eight weeks.
The company is using a new production method, involving a simpler device. This will enable GSK to increase production capacity by another 100 million packs and make it easier to license the drug to other firms. - CNA/vm